Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Current landscape of clinical use of ex vivo expanded natural killer cells for cancer therapy.
Azevedo JTC, Godoy JAP, Souza C, Sielski MS, Coa LL, Barbosa Júnior A, Kerbauy LN, Kondo AT, Okamoto OK, Hamerschlak N, Kutner JM, Paiva RMA. Azevedo JTC, et al. Among authors: kerbauy ln. Einstein (Sao Paulo). 2024 Dec 9;22:eRW0612. doi: 10.31744/einstein_journal/2024RW0612. eCollection 2024. Einstein (Sao Paulo). 2024. PMID: 39661859 Free PMC article. Review.
Immune reconstitution dynamics after unrelated allogeneic transplantation with post-transplant cyclophosphamide compared to classical immunosuppression with anti-thymocyte globulin: a prospective cohort study.
Kerbauy MN, Rocha FA, Arcuri LJ, Cunegundes PS, Kerbauy LN, Machado CM, Ribeiro AAF, Banerjee PP, Marti LC, Hamerschlak N. Kerbauy MN, et al. Among authors: kerbauy ln. Haematologica. 2024 Sep 12. doi: 10.3324/haematol.2024.285921. Online ahead of print. Haematologica. 2024. PMID: 39279428 Free article.
BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AML.
Kumar B, Singh A, Basar R, Uprety N, Li Y, Fan H, Cortes AKN, Kaplan M, Acharya S, Shaim H, Xu AC, Wu M, Ensley E, Fang D, Banerjee PP, Garcia LM, Tiberti S, Lin P, Rafei H, Munir MN, Moore M, Shanley M, Mendt M, Kerbauy LN, Liu B, Biederstädt A, Gokdemir E, Ghosh S, Kundu K, Reyes-Silva F, Jiang XR, Wan X, Gilbert AL, Dede M, Mohanty V, Dou J, Zhang P, Liu E, Muniz-Feliciano L, Deyter GM, Jain AK, Rodriguez-Sevilla JJ, Colla S, Garcia-Manero G, Shpall EJ, Chen K, Abbas HA, Rai K, Rezvani K, Daher M. Kumar B, et al. Among authors: kerbauy ln. Sci Transl Med. 2024 Sep 11;16(764):eadp0004. doi: 10.1126/scitranslmed.adp0004. Epub 2024 Sep 11. Sci Transl Med. 2024. PMID: 39259809
An Extended Flow Cytometry Evaluation of ex Vivo Expanded NK Cells Using K562.Clone1, a Feeder Cell Line Manufactured in Brazil.
Watanabe CM, Suzuki CI, Dos Santos AM, Aloia TPA, Lee G, Wald D, Okamoto OK, de Azevedo JTC, de Godoy JAP, Santos FPS, Weinlich R, Kerbauy LN, Kutner JM, Paiva RMA, Hamerschlak N. Watanabe CM, et al. Among authors: kerbauy ln. Transplant Cell Ther. 2024 Nov;30(11):1063.e1-1063.e19. doi: 10.1016/j.jtct.2024.07.004. Epub 2024 Jul 8. Transplant Cell Ther. 2024. PMID: 38986739
Author Correction: KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape.
Li Y, Basar R, Wang G, Liu E, Moyes JS, Li L, Kerbauy LN, Uprety N, Fathi M, Rezvan A, Banerjee PP, Muniz-Feliciano L, Laskowski TJ, Ensley E, Daher M, Shanley M, Mendt M, Acharya S, Liu B, Biederstädt A, Rafei H, Guo X, Melo Garcia L, Lin P, Ang S, Marin D, Chen K, Bover L, Champlin RE, Varadarajan N, Shpall EJ, Rezvani K. Li Y, et al. Among authors: kerbauy ln. Nat Med. 2024 Mar;30(3):906. doi: 10.1038/s41591-023-02770-1. Nat Med. 2024. PMID: 38182787 No abstract available.
Cellular therapy in lymphoma.
Sureda A, Lugtenburg PJ, Kersten MJ, Subklewe M, Spanjaart A, Shah NN, Kerbauy LN, Roddie C, Pennings ERA, Mahuad C, Poon M, Hendricks CL, Kamdar M, Jacobson C. Sureda A, et al. Among authors: kerbauy ln. Hematol Oncol. 2024 Nov;42(6):e3200. doi: 10.1002/hon.3200. Epub 2023 Jun 29. Hematol Oncol. 2024. PMID: 37382086 Review.
Molecular profile of patients with myelofibrosis: a 10-year experience.
Dias LFS, Pereira CLM, Centurião NF, Nascimento JZMD, Ribeiro AAF, Hamerschlak N, Marques CP, Lima ACV, Costa LND, Silva AFD, Lima VJT, Kerbauy MN, Kerbauy LN, Arcuri LJ, Campregher PV, Rocha JDAD, Datoguia TS, Santos FPS. Dias LFS, et al. Among authors: kerbauy ln. Einstein (Sao Paulo). 2023 Jan 6;21:eAO0100. doi: 10.31744/einstein_journal/2023AO0100. eCollection 2023. Einstein (Sao Paulo). 2023. PMID: 36629680 Free PMC article.
Activated B cells suppress T-cell function through metabolic competition.
Imahashi N, Basar R, Huang Y, Wang F, Baran N, Banerjee PP, Lu J, Nunez Cortes AK, Uprety N, Ensley E, Muniz-Feliciano L, Laskowski TJ, Moyes JS, Daher M, Mendt M, Kerbauy LN, Shanley M, Li L, Lim FLWI, Shaim H, Li Y, Konopleva M, Green M, Wargo J, Shpall EJ, Chen K, Rezvani K. Imahashi N, et al. Among authors: kerbauy ln. J Immunother Cancer. 2022 Dec;10(12):e005644. doi: 10.1136/jitc-2022-005644. J Immunother Cancer. 2022. PMID: 36543374 Free PMC article.
KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape.
Li Y, Basar R, Wang G, Liu E, Moyes JS, Li L, Kerbauy LN, Uprety N, Fathi M, Rezvan A, Banerjee PP, Muniz-Feliciano L, Laskowski TJ, Ensley E, Daher M, Shanley M, Mendt M, Acharya S, Liu B, Biederstädt A, Rafei H, Guo X, Melo Garcia L, Lin P, Ang S, Marin D, Chen K, Bover L, Champlin RE, Varadarajan N, Shpall EJ, Rezvani K. Li Y, et al. Among authors: kerbauy ln. Nat Med. 2022 Oct;28(10):2133-2144. doi: 10.1038/s41591-022-02003-x. Epub 2022 Sep 29. Nat Med. 2022. PMID: 36175679 Free PMC article.
29 results